Drug Approval | May 26, 2022
Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The company has 47 ANDA's pending approval with the U.S.FDA
It is indicated for the treatment of patients with acromegaly and Gastroenteropancreatic Neuroendocrine Tumours
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Nelarabine is in a class of medications called antimetabolites
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
Subscribe To Our Newsletter & Stay Updated
